ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

DePinho Bets MD Anderson Credibility On His Cancer “Moon Shot” Program

September 7, 2012

Interferon Alpha-2B Effective For Malignant Melanoma

July 27, 2001

Clinical Trials Approved By NCI

October 31, 2003

NCI-Approved Clinical Trials

June 25, 2004

Chemical Society Designates Taxol, Camptothecin Discoveries Historic

April 25, 2003

ACCC Seeking Line Item, $21 Million for CCPs; Results Of Evaluation Released

June 5, 1987